Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Morimoto

Showing results (131-140 of 991) with videos related to

Pageof 100
Sort By:
European Journal of Pharmacology|January 5, 1993
Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized ratsY Matsumura, K Fujita, M Takaoka, et al.
Journal of Pharmacobio-Dynamics|March 1, 1985
Renal inactive kallikrein as the possible origin of urinary inactive kallikrein in the ratH Okamura, M Takaoka, T Iwamoto, et al.
Japanese Journal of Medicine|July 1, 1989
Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumorK Uchida, T Kigoshi, R Iwasaki, et al.
The Biochemical Journal|August 15, 1997
Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor familyH Toyoda, T Komurasaki, D Uchida, et al.
Oncogene|January 7, 1998
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4T Komurasaki, H Toyoda, D Uchida, et al.
Acta Endocrinologica|August 1, 1976
Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysisR Takeda, S Morimoto, K Uchida, et al.
Acta Endocrinologica|July 1, 1989
Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronismR Iwasaki, T Kigoshi, K Uchida, et al.
Uchu Seibutsu Kagaku|May 9, 2002
[Estimation for biological effects of heavy-ion exposure in space environment]F Yatagai, S Goto, S Morimoto, et al.
Plant Cell Reports|November 2, 2013
Cannabis 25 (1), biotransformation of cannabidiol and cannabidiolic acid by Pinellia ternata tissue segmentsH Tanaka, R Takahashi, S Morimoto, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|September 1, 1992
[An 88-year-old female case of hyperalphalipoproteinemia associated with deficiency of cholesteryl-ester transfer activity]Y Miyashita, S Morimoto, K Fukuo, et al.
Pageof 100

Showing results (131-140 of 991) with videos related to

Sort By:
Pageof 100
European Journal of Pharmacology|January 5, 1993
Big endothelin-3-induced hypertension and its inhibition by phosphoramidon in anaesthetized ratsY Matsumura, K Fujita, M Takaoka, et al.
Journal of Pharmacobio-Dynamics|March 1, 1985
Renal inactive kallikrein as the possible origin of urinary inactive kallikrein in the ratH Okamura, M Takaoka, T Iwamoto, et al.
Japanese Journal of Medicine|July 1, 1989
Altered responses of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II and adrenocorticotropin in patients with a 18-hydroxycorticosterone-producing tumorK Uchida, T Kigoshi, R Iwasaki, et al.
The Biochemical Journal|August 15, 1997
Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor familyH Toyoda, T Komurasaki, D Uchida, et al.
Oncogene|January 7, 1998
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4T Komurasaki, H Toyoda, D Uchida, et al.
Acta Endocrinologica|August 1, 1976
Changes in plasma renin activity and plasma aldosterone in the induced paralytic attack of thyrotroxic periodic paralysisR Takeda, S Morimoto, K Uchida, et al.
Acta Endocrinologica|July 1, 1989
Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronismR Iwasaki, T Kigoshi, K Uchida, et al.
Uchu Seibutsu Kagaku|May 9, 2002
[Estimation for biological effects of heavy-ion exposure in space environment]F Yatagai, S Goto, S Morimoto, et al.
Plant Cell Reports|November 2, 2013
Cannabis 25 (1), biotransformation of cannabidiol and cannabidiolic acid by Pinellia ternata tissue segmentsH Tanaka, R Takahashi, S Morimoto, et al.
Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics|September 1, 1992
[An 88-year-old female case of hyperalphalipoproteinemia associated with deficiency of cholesteryl-ester transfer activity]Y Miyashita, S Morimoto, K Fukuo, et al.
Pageof 100